⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
REGN News
Regeneron Pharmaceuticals Inc
Chronic Kidney Disease Market Poised to Expand Significantly During Forecast Period (2025-2034) as Demand for Early Diagnosis and Novel Therapies Increases | DelveInsight
prnewswire.com
MLYS
PROK
IRON
REGN
AMGN
MAZE
LLY
JNJ
LXRX
7MM Asthma Market Insights, Epidemiology, and Market Forecast Report 2022-2036
globenewswire.com
SNY
REGN
AMGN
AZN
GSK
NVS
TEVA
COMPUTEX 2026 Brings the Global AI Ecosystem to Taipei
prnewswire.com
MSI
INTC
TXN
NVDA
AMAT
KLAC
LRCX
MU
QCOM
AMD
GOOG
MSFT
AMZN
IBM
DELL
HPQ
VRTX
ADI
NXPI
ON
MCHP
SNPS
CDNS
MRVL
ADSK
CTAS
PAYX
ADP
CRM
NOW
PANW
FTNT
ZBRA
HON
GE
ROK
ETN
GOOGL
META
NFLX
DIS
CMCSA
T
VZ
TMUS
CSCO
ORCL
SAP
ACN
DXC
WDC
SE
SMCI
DDOG
MDB
ZS
CRWD
SNOW
PLTR
UPST
COIN
PYPL
AFRM
SOFI
HOOD
UPWK
FIVN
RBLX
EA
TTWO
U
EXAS
REGN
BIIB
GILD
AMGN
BMY
PFE
MRK
JNJ
ABBV
LLY
NVO
AZN
XOM
CVX
SHEL
BABA
JD
PDD
NTES
BIDU
VIPS
EDU
BEKE
TAL
BILI
RLX
XPEV
NIO
LI
CPT
LCID
RIVN
TSLA
GM
F
STLA
VWAGY
HOG
YETI
GOOS
LULU
UA
NKE
ANF
AEO
URBN
PVH
RL
TJX
M
BBY
WMT
COST
TGT
HD
LOW
SPG
PLD
AMT
EQIX
CCI
DLR
SBAC
Obesity Care Week 2026 Calls for Action to Improve Access to Obesity Care
prnewswire.com
LLY
GNE
REGN
AMGN
BSX
CURX
NVO
ZETA
Press Release: Sanofi and Regeneron’s Dupixent recommended for EU approval to treat chronic spontaneous urticaria in young children with ongoing symptoms despite treatment
globenewswire.com
REGN
SNY
Dupixent® (dupilumab) Recommended for EU Approval to Treat Chronic Spontaneous Urticaria (CSU) in Young Children with Ongoing Symptoms Despite Treatment
globenewswire.com
SNY
REGN
Santhera Announces Proposed Inclusion and Reimbursement of AGAMREE® (Vamorolone) within Spain’s National Health System for the Treatment of Duchenne Muscular Dystrophy
globenewswire.com
CRSP
REGN
PTGX
Regeneron Renews Sponsorship of the Regeneron Science Talent Search Through 2036, Committing an Additional $150 Million to Empower the Next Generation of Science and Technology Leaders
globenewswire.com
REGN
Regeneron Renews Sponsorship of the Regeneron Science Talent Search Through 2036, Committing an Additional $150 Million to Empower the Next Generation of Science and Technology Leaders
globenewswire.com
REGN
The International Myeloma Foundation Invites the Myeloma Community to Demonstrate the Spirit of #MoreThanMyeloma for 2026 Myeloma Action Month
globenewswire.com
GSK
JNJ
PFE
REGN
SNY
AMTX
ATHA
TMO
GILD